A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis

Arthritis and Rheumatology

Volumn 67, Issue 6, 2015, Pages 1611-1622

  Spadoni, Tatiana ^a   Svegliati Baroni, Silvia ^a   Amico, Donatella ^a   Albani, Lisa ^a   Moroncini, Gianluca ^a   Avvedimento, Enrico V ^b   Gabrielli, Armando ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DACTINOMYCIN; DIPHENYLIODONIUM SALT; DNA A; IMMUNOGLOBULIN G; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; NOX4 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA REPAIR; ENZYME ACTIVITY; FEMALE; FIBROBLAST CULTURE; FLUOROMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; UPREGULATION; CELL CULTURE; CYTOLOGY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; SKIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; FLUOROMETRY; GENE SILENCING; HUMANS; IMMUNOBLOTTING; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SCLERODERMA, SYSTEMIC; SKIN;

EID: 84929902758     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39084     Document Type: Article

References (50)

1. Gabrielli A, Avvedimento EV, Krieg T., Scleroderma. N Engl J Med 2009; 360: 1989-2003.
2. Varga J, Abraham DJ., Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117: 557-67.
3. Gabrielli A, Svegliati S, Moroncini G, Amico D., New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol J 2012; 6: 87-95.
4. Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV., Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. Semin Immunopathol 2008; 30: 329-37.
5. Dooley A, Low SY, Holmes A, Kidane AG, Abraham DJ, Black CM, et al., Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis. Rheumatology (Oxford) 2008; 47: 272-80.
6. Yamamoto T., The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Arch Dermatol Res 2006; 297: 333-44.
7. Noguchi S, Yatera K, Wang KY, Oda K, Akata K, Yamasaki K, et al., Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice. Respir Res 2014; 15: 92.
8. Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C, et al., Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 2009; 182: 5855-64.
9. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al., Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44: 2653-64.
10. Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, et al., Platelet-derived growth factor and reactive oxygen species regulate Ras protein levels in primary human fibroblasts via ERK1/2: amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005; 280: 36474-82.
11. Svegliati S, Marrone G, Pezone A, Spadoni T, Grieco A, Moroncini G, et al., Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the WNT inhibitor WIF-1 in systemic sclerosis and fibrosis. Sci Signal 2014; 7: ra84.
12. Bedard K, Krause KH., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
13. Droge W., Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
14. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J., Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
16. LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 12: 217-23.
17. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al., Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
18. Block K, Gorin Y, Abboud HE., Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 2009; 106: 14385-90.
19. Collins AR, Duthie SJ, Dobson VL., Direct enzymatic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993; 14: 1733-5.
20. Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, et al., The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 2012; 69: 2327-43.
21. Fuzii HT, Yoshikawa GT, Junta CM, Sandrin-Garcia P, Fachin AL, Sakamoto-Hojo ET, et al., Affected and non-affected skin fibroblasts from systemic sclerosis patients share a gene expression profile deviated from the one observed in healthy individuals. Clin Exp Rheumatol 2008; 26: 866-74.
22. Lee DY, Wauquier F, Eid AA, Roman LJ, Ghosh-Choudhury G, Khazim K, et al., Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II. J Biol Chem 2013; 288: 28668-86.
23. Svegliati Baroni S, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al., Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354: 2667-76.
24. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ., ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276: 42462-7.
25. Moore BB, Hogaboam CM., Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008; 294: L152-60.
26. Bohm M, Dosoki H, Kerkhoff C., Is Nox4 a key regulator of the activated state of fibroblasts in systemic sclerosis? Exp Dermatol 2014; 23: 679-81.
27. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, et al., Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 40: 79-82.
28. Kleniewska P, Piechota A, Skibska B, Goraca A., The NADPH oxidase family and its inhibitors. Arch Immunol Ther Exp (Warsz) 2012; 60: 277-94.
29. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, et al., Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003; 18: 2164-71.
30. Zhang M, Shah AM., ROS signalling between endothelial cells and cardiac cells. Cardiovasc Res 2014; 102: 249-57.
31. Geiszt M, Kopp JB, Varnai P, Leto TL., Identification of Renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 2000; 97: 8010-4.
32. Lassegue B, Griendling KK., NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010; 30: 653-61.
33. Tobar N, Toyos M, Urra C, Mendez N, Arancibia R, Smith PC, et al., c-Jun N terminal kinase modulates NOX-4 derived ROS production and myofibroblasts differentiation in human breast stromal cells. BMC Cancer 2014; 14: 640.
34. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, et al., NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 2007; 406: 105-14.
35. Mittal M, Roth M, Konig P, Hofmann S, Dony E, Goyal P, et al., Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 2007; 101: 258-67.
36. Hwang J, Ing MH, Salazar A, Lassegue B, Griendling K, Navab M, et al., Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res 2003; 93: 1225-32.
37. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, et al., NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005; 97: 900-7.
38. 1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am J Physiol Renal Physiol 2014; 307: F159-71.
39. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, et al., Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767-75.
40. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, et al., NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009; 15: 1077-81.
41. Jiang JX, Venugopal S, Serizawa N, Chen X, Scott F, Li Y, et al., Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 2010; 139: 1375-84.
42. Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, et al., Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 2012; 53: 289-96.
43. Amara N, Goven D, Prost F, Muloway R, Crestani B, Boczkowski J., NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts. Thorax 2010; 65: 733-8.
44. Jarman ER, Khambata VS, Cope C, Jones P, Roger J, Ye LY, et al., An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model. Am J Respir Cell Mol Biol 2014; 50: 158-69.
45. 2 production downstream of FLT3 is mediated by p22phox in the endoplasmic reticulum and is required for STAT5 signalling. Plos One 2012; 7e34050.
46. Sampson N, Koziel R, Zenzmaier C, Bubendorf L, Plas E, Jansen-Durr P, et al., ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol Endocrinol 2011; 25: 503-15.
47. Block K, Eid A, Griendling KK, Lee DY, Wittrant Y, Gorin Y., Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 2008; 283: 24061-76.
48. Sampson N, Berger P, Zenzmaier C., Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease. Biomed Res Int 2014;2014; 131737.
49. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, et al., Reversal of persistent fibrosis in aging by targeting NOX4-Nrf2 redox imbalance. Sci Transl Med 2014; 6: 231ra47.
50. Vecchio D, Acquaviva A, Arezzini B, Tenor H, Martorana PA, Gardi C., Downregulation of NOX4 expression by roflumilast N-oxide reduces markers of fibrosis in lung fibroblasts. Mediators Inflamm 2013;2013: 745984.